Measuring the Brain’s Amyloid Buildup Less Effective in Identifying Severity, Progression of Alzheimer’s Disease Compared to Other Imaging Methods

While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer’s disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Thomas Jefferson University.